Picture of Avecho Biotechnology logo

AVE Avecho Biotechnology News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Avecho Biotechnology Receives Ethics Approval For CBD Human Trial

April 13 (Reuters) - Avecho Biotechnology Ltd  AVE.AX :
    * AVECHO RECEIVES ETHICS APPROVAL FOR CBD HUMAN TRIAL
    * HAS COMMENCED PLANNING FOR CBD DEVELOPMENT PROGRAM BEYOND
PHASE
I, WITH A FOCUS ON TGA REGISTRATION

Source text for Eikon:  ID:nASX2HZF3d 
Further company coverage:  AVE.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Avecho Biotechnology

See all news